Slides
Page 1
Crop Science Investor Update 2026 September 2 nd 2026
Page 2
2 /// Bayer Crop Science 2026 Our Agenda today 2 /// Bayer Crop Science 2026 Welcome and Opening Remarks Rodrigo Santos, President, Crop Science Capital Market Update Presentation Rodrigo Santos, President, Crop Science Guru Ramamurthy, CFO, Crop Science Sascha Israel, Head of Product Supply, Crop Science Q&A Field Tour Multiple Bayer Crop Science Leaders and Scientists Lunch - BBQ & Networking - 08:30 – 08:45 08:45 – 11:00 11:45 – 12:30 12:30 – 13:15 13:15 – 16:15 16:15 – 18:30 Mike Graham, Head of R&D, Crop ScienceR&D 11:00 – 11:45 Rodrigo Santos, Guru Ramamurthy, Sascha Israel, Mike Graham Chapter Speaker Time Jana Ackermann, Head of Investor Relations, Bayer AG
Page 3
/// Bayer Crop Science 20263 Welcome and Opening Remarks
Page 4
4 /// Bayer Crop Science 2026 Cautionary Statements Regarding Forward-Looking Information This presentation may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments. Bayer AG is a holding company with operating subsidiaries worldwide. References to “Bayer” or “the company” herein may refer to one or more subsidiaries as context requires. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at h t t p : / / w w w. b a y e r. c o m/
Page 5
5 /// Bayer Crop Science 2026 Bayer is a global innovation leader in Health & Nutrition: Crop Science is our largest division g Crop ScienceNet sales full year 2025 as rep1 Core EPS Full Year 20253 €4.57 Free Cash Flow Full Year 2025 €2.1bn €45.6bn ~+1% CAGR2 Resilient financial profile 1. As rep = as reported 2. CAGR 2021-2025 3. Changed Core EPS methodology for 2026, now incl. regular amortization of certain intangible assets, mainly software; prior year Core EPS restated 47% 39% 13% Crop Science Pharma Consumer Health Attractive and growing global market Leading positions in Seed & Traits and Crop Protection Industry leading innovation engine Long-term value creation and shareholder returns Enduring growth contribution Strong cash generation
Page 6
/// Bayer Crop Science 20266 Bayer Crop Science Highlights
Page 7
/// Bayer Crop Science 20267 - Attractive market Global seed and CP market structurally growing at ~2% (CAGR 2025-2030) driven by global megatrends Highlights | BCS is poised to deliver durable value creation – building on its strengthened financial profile and unique offering We are the leading global innovator of S&T and CP solutions, delivered to growers and their multi-year, multi-crop systems in all relevant markets by our farmer-centric go-to-market model Winning business model Strengthened financial delivery We are rigorously executing our margin & cash measures to strengthen our financial profile; these are fully under our control and will deliver >€1bn cEBITDA uplift and FOCF >€3bn by 2029 Durable value creation We will outgrow the market with our industry-leading innovation pipeline that delivers >400 new hybrids & varieties p.a., Trait & CP blockbusters, and expansion opportunities beyond the core Leading R&D for long-term success We are fueling the next wave of innovations and growth in the 2030s through our AI- empowered R&D capabilities across breeding, biotech, and chemical discovery Governed by Five-Year Framework
Page 8
/// Bayer Crop Science 20268 Market Update Outlook on the Seeds & Traits and Crop Protection Markets
Page 9
9 /// Bayer Crop Science 2026 1. UNDESA 2024 (United Nations Department of Economic and Social Affairs, Population Division (2024). World Population Prospe cts: The 2024 Revision) 2. Compared to 2025, S&P Global Energy 2026 3. By 2035, OECD-FAO Agricultural Outlook 2026-35 4. By the end of century, varying by crops. Hultgren et. al, (2025) 5. Heap, Intl. Survey of Herbicide -Resistant Weeds (Global count unique cases, Average annual increase of unique cases 1975 - 2025) 6. FAO Saving our soils by all earthly ways possible Innovations are key to solving the challenges in agriculture Agriculture is a critical industry and must produce more on every acre to meet future demand Growing demand Pressure on supply Growing population with +1.5bn (+18%) people on the planet by 20501 Rising biofuel mandates driving 1.5x demand growth to ~65bn gal in 20352 Dietary trends, e.g., 12% meat con- sumption uplift3 drives feed crops demand 11-25% harvest loss risk from climate change4 >10 new resistant weed cases annually; ~550 recorded to date5 90% of all soils at risk to be degraded by 20506 Increasing pressure on productivity
Page 10
10 /// Bayer Crop Science 2026 /// Bayer Crop Science 2026 57 40 2015 69 49 2025 75 56 2030 2035 +2% Seeds & Traits Crop Protection Global S&T and CP market in €bn Market outlook CAGR +2% Market expected to move into upcycle, resulting in ~2% CAGR from '25 to '30 In S&T, 2-3% CAGR expected from acreage expansion, GMO2 liberalization (China), and novel traits Additional growth from new value pools, e.g., novel biofuel crops and biologicals3 In CP, 1-2% CAGR expected, volume growth partially offset by price pressure from low-cost Gx producers in China New value pools CAGR ('25-'30)1 2 - 3% 1 - 2% 10 S&T and CP markets are on a solid long-term growth trajectory 1. At plan rates 2026 used in Five-Year Framework 2. Genetically modified organism 3. Includes biostimulants and biofertility solutions; biocontrol represented in CP market values; some biofuel crops fall into existing S&T segments Source: AgbioInvestor and internal assessment
Page 11
/// Bayer Crop Science 202611 Our Business Model Business Setup and Steering Approach
Page 12
12 /// Bayer Crop Science 2026 Leading platform positions | … We are the clear market leader in the S&T and CP market, with leading positions across all our platforms Core CP 1. Market shares and positions calculated based on reported segment sales FY2025 relative to latest internal sell-in market size estimates; in scope for the ranking are all publicly listed companies and private companies with financial disclosures comparable to publicly listed companies 2. #1 for Cotton, #2 for Vegetable, #3 for Canola 3. Including glyphosate and other non-selective herbicide products 4. Core CP net sales includes all CP sales excl. glyphosate; Glyphosate 2025 Net sales amounted to €2.5bn S&T Herbicides3 Fungicides #1 #2 #3 Insecticides Strong portfolio focusing on combining high efficacy & low environmental impact Corn Soy Other Market leading positions across all key crops, backed by a strong global germplasm base and a rich, cross-crop trait pipeline that meets farmers' most critical needs Global market position1 #1 2025 Net sales €7.1bn Global market share1 ~35% #1 2025 Net sales €2.2bn ~30% #1-32 2025 Net sales €1.8bn Global market share1 (Cotton) ~35% Global market position1 Global market position1 Global market share1 Non-Core CP (incl. Ruveon) End-to-end value chain coverage, only glyphosate producer outside China Global market position #1 2025 Net sales €2.5bn ~40% Global market share1 #2 2025 Net sales €8.0bn Global market share1 ~12% Global market position1
Page 13
13 /// Bayer Crop Science 2026 Our leading industry position is underpinned by five competitive differentiators 1 Leading portfolio in each product segment: Best performing products in all key platforms 2 Resilient CP and seed supply chain: Secured AI access and robust seed production 3 GTM with largest reach across key markets: High customer proximity and grower trust Our key differentiators 4 Leading R&D capabilities in all tech stacks: Strongest innovation pipeline in the industry Our business model Key capabilities Go-to-market Innovation Proven ability to unlock new value pools: Vast growth opportunities in adjacencies 5 New Value PoolsCoreCorn Soy Other S&T Bayer CS core platforms Non- Core1 CP 1. Including Ruveon, US Glyphosate business as by announcement from 07/01/26 Note: AI = Active Ingredient Product supply Enabled by digital solutions & Artificial Intelligence
Page 14
14 /// Bayer Crop Science 2026 Our portfolio and innovations unlock value on every acre in every year /// Bayer Crop Science 2026 We are the only provider in the market who can offer full multi-year, multi-crop solutions, including S&T, CP, digital, and new value pools Market evolution: From individual products To combination of systems across seasons that deliver farmer profits & resilience 14 1. This slide is aspirational and may be subject to regulatory approvals and final verification 2. Preliminary scientific re search indicates that deeper roots facilitate enhanced exploration of the soil profile for improved access to water and nutrient s 3. Initial data shows potential carbon sequestration benefits, which may enable farmers to capitalize on the commercialization of low carbon intensity fuel feedstoc k for the biofuels sector 4. Pending EPA label approval 5. This product is not currently available for commercial sale or commercial planting. Commercialization is dependent on multiple factors, including successful conclusion of the regulatory process. The information presented herein is provided for educational purposes only, and is not and shall not be construed as an offer to sell.
Page 15
15 /// Bayer Crop Science 2026 Within our business model, we pursue differentiated strategies by platform to maximize impact and value creation Corn (Seeds & Traits) Strengthen #1 position via innovation, geographic expansion, go-to-market Soy (Seeds & Traits) Defend acreage share and prepare innovation-driven growth for 2028+ Other S&T (Cotton, Canola, F&V) Expand market share in Canola, Cotton, Veg via S&T innovation & commercial reach Strategic directionPlatform Core CP (HER, FUN, INS) Drive profitable growth via targeted R&D, focused GTM, and optimized COGS Non-Core CP (incl. Ruveon1) Optimize operations for efficiency through ultra-lean, dedicated business model New Value Pools (e.g., Biofuels, Blx) Build leading position and strong partnerships in emerging market segments 1. US Glyphosate business as per announcement from 07/01/26
Page 16
/// Bayer Crop Science 202616 Five-Year Framework – Progress Update Detailed View on Progress towards 2029 Ambition
Page 17
17 /// Bayer Crop Science 2026 Our Five-Year Framework continues to be the top priority Other S&T Soy S&T Corn S&T Strengthen the foundation In execution GTM & Global functions Product supply Portfolio & R&D Cash Capitalize pipeline value in Core Core CP Accelerating 2027 and beyond Cash Flow Dynamic Shared Ownership >€1.0bn Margin improvements '24-'291 >€1.5bn Cumulative cash freed from working capital '24-'292 Margin Sales >€3.5bn Incremental net sales incl. innovation '24-'291 Non-Core CP Expand beyond the Core into New Value Pools 2030+ Biological solutions Biofuel seeds Biological solutions Biofuel seeds Hybrid wheat 1. At constant currency and portfolio adjusted 2. Cumulative cash impact '24-'29, incrementally on top of cEBITDA effect
Page 18
18 /// Bayer Crop Science 2026 A disciplined and adaptable execution framework supports delivery of our Five-Year Framework Rigorous 90-day sprint cadence, ensuring fast paced progress and high level of adaptability Dedicated delivery teams, driving disciplined execution of initiatives Effective works council collaboration, allows appropriate speed of implementation Harmonized team incentives, link realization of our ambition to personal compensation Cash Flow Dynamic Shared Ownership Margin Sales Committed Executive sponsors, accountable for delivering targeted value
Page 19
19 /// Bayer Crop Science 2026 Margin Margin Product supply (COGS) Portfolio & R&D GTM & Global functions Progress on '29 ambition | We have already delivered ~€380m run rate cEBITDA uplift and are on track to achieve our 2029 ambition 1. For Margin and Cash categories: cEBITDA impact by '29 2. Impact from R&D initiative only; does not include negative gross profit impact of divestments and portfolio pruning 3. €3.5bn is the resulting target from above market cpa growth, not reflecting FX; Confirming 2026 guidance 4. Cumulative cpa growth / 1% cpa growth delivered in 2025, 1.5% cpa growth as mid-point of 2026 guidance (0-3%cpa growth) 5. Cumulative cash impact '24-'29, incrementally on top of cEBITDA effect Note: Working capital efficiencies are derived from YoY improvements in underlying working capital KPIs, adjusted for FX and other non-cash effects. Progress is measured through inventory productivity, customer cash collection efficiency, and supplier payment-term optimization From R&D spend >€150m2 From COGS >€600m From SG&A >€400m Initiative cumulative cash freed from working capital >€1.5bn5 Margin (run rate impact) Cash Cash flow Ambition by 20291 Progress and trajectory Marginincremental net sales (cpa) Above market growth >€3.5bn3 Sales Sales ~10 ~40 >150 ~100 ~250 >600 ~10 ~90 >400 ~700 ~1,000 >1,500 2025 2026 2029 ~220 ~5504 >3,500 Portfolio streamlining On track R&D efficiency On track GTM differentiation On track Global functions setup On track CP sourcing improvements Ahead of schedule CP production network On track Seed production network On track Supplier cash improvements On track Customer cash improvements On track Inventory reduction Ahead of schedule Sales growth On track Execution-led initiatives
Page 20
20 /// Bayer Crop Science 2026 Strengthen the foundation Other S&T Soy S&T Corn S&T Strengthen the foundation GTM & Global functions Product supply Portfolio & R&D Cash Core CP Capitalize pipeline value in Core Expand beyond the Core Biological solutions Biofuel seeds Progress towards 2029 ambition Inventory reduction of €500m already achieved in 2025; further €300m in implementation Supplier payment terms extended by 4 days and sales outstanding reduced by 2 days CP Sourcing and process improvements ahead of schedule – >€200m run rate cEBITDA delivered CP and seed network adjustments on track – full cost impact effective in 2029 1 GTM adjustments in "Harvest" and "Leverage" countries already freed up ~100 FTE Refined channel partner and demand generation approach to improve gross-to-net realization3 4 Hybrid wheat Non-Core CP 1. The Preceon Smart Corn System, including short stature corn products developed through traditional breeding, is commercially available for planting in the 2026 growing season through a Preceon Certified Advisor. 2. This product is not currently available for commercial sale or commercial planting. Commercialization is dependent on multiple factors, including successful conclusion of the regulatory process. The information presented herein is provided for educational purposes only, and is not and shall not be construed as an offer to sell. Note: AI = Active Ingredient; SPG = Strategic Product Group 2 CP portfolio streamlining on track – 5 margin dilutive AIs divested, >100 SPGs discontinued R&D efficiency measures and network adjust- ments well on track for full realization by 2029
Page 21
21 /// Bayer Crop Science 2026 Progress towards 2029 ambition (Run-rate cEBITDA impact in €m) Product supply (COGS) | We optimize our sourcing & production cost position, esp. in CP Secured €200m cost improvement via price reduction for raw materials & intermediates and technical improvements Progressing with network adjust- ments for AI and FFP; structural changes and full cost impact effective in 2029 Reducing AI in-house production share from 34% to 26% Implemented first wave of structural improvements to seed production, logistics & warehousing cEBITDA impact by '29 from COGS measures Lower structural production costs More adaptable product supply Resilient supply chain Our 2029 ambition 40 2026 2027 2028 2029 ~120 200 2026 2027 2028 2029 ~240 10 2026 2027 2028 2029 >240 Initiative CP sourcing & process improvements Seed production optimization Crop Protection production network Note: AI = Active Ingredient; FFP = Formulation, filling, packaging /// Bayer Crop Science 202621 Ahead of schedule On track On track >€600m
Page 22
22 /// Bayer Crop Science 2026 CP sourcing & process improvement | We have already achieved ~€200m COGS improvement Note: AI = Active Ingredient Raw material & AI deflation Sourcing shifts Process optimization Key actions Realized impact Progress towards ambition Re-negotiation of AIs, pre- cursors, and raw materials with existing & new suppliers Joint optimization with strategic partners to unlock end- to-end cost advantages Fast-track outsourcing analysis and implementation for >10 AIs and pre-cursors Focus on best-cost supply for outsourced molecules 14 E2E optimization squads focused on technical improvements (e.g., yield, waste, process) for top molecules Successful leverage of Artificial Intelligence to scale coverage of optimization teams €200m Run rate savings delivered by end of Q2, 2026 Further improvements in implementation or already in transition to P&L via inventory
Page 23
23 /// Bayer Crop Science 2026 Update on key implementation projects Edited CP production network | We are on track to deliver >€240m savings from our Crop Protection network optimization Dormagen / Knapsack Frankfurt Kansas City Formulation, filling, packaging sites (FFP) Consolidation of 3 out of 6 plants in Dormagen Knapsack site integrated with Dormagen Full exit of Bayer activities in Frankfurt Consolidation of 1 out of 2 plants Rightsizing of utilities ~20-25% adjustment of formulation capacity and focus on future technologies Target >€100m >€100m >€40m Impact 2029 2027-202920292027-2029Imple- mentation Progress Signed joint declaration (Germany) Technical transfers and transition stock building on track Decided / in process of finalizing future supply contracts in line with or better than plan Two site closures already implemented NA formulation site Shakopee (US) Southeast Asian formulation site BangPoo (TH) Divestment/closure of Frankfurt FFP site on track On trackOn track
Page 24
24 /// Bayer Crop Science 2026 Streamlining Seed production optimization | Seed network actively reshaped in line with differentiated platform strategies Divested Windfall site in March 2026 Adjusted seed multiplica- tion contracts for flexibility and resilience Opened in March 2025 as distribution hub in Africa Expected to supply high- yielding corn seeds to ~10m farmers by 2030 Opening corn seed site in Kabwe, Zambia Warehouse & logistics Significantly increased direct customer shipments Optimized warehouse net- work with ~10% decrease of contracted storage Invest for corn growth through geo expansion Improve soy cost structure through fix cost reduction Focus on additional fixed cost improvements Refining soy logistics in US Divesting soy processing in Windfall, IN Expansion Opening corn seed site in Kabwe, Zambia Continuing to improve in line with market requirements and growth opportunities World leading seed production with strong improvement track record Improvement in Corn COGS ratio over the last three years ~200 basis pt. Continued gains expected over next 3 years Benchmark seed production setup
Page 25
25 /// Bayer Crop Science 2026 Strong confidence to deliver >600m EBITDA improvement from COGS until ‘29 On track or ahead of schedule on measure implementation Note: AI = Active Ingredient, FFP = Formulation, filling, packaging We are well on track to set up operations for the future and achieve our 2029 COGS ambition Lower structural cost Improved utilization Resilience & flexibility Seed production optimization On track CP Production network On track Progress on Five-Year Framework On track Continued benchmark productivity & quality performance Ready to support geographic- and product expansion Additional booster from structural measures Future network with improved capacity utilization & competitive cost of AIs More flexibility via rebalancing of internal and external sourcing Leaner FFP aligned to future technologies
Page 26
26 /// Bayer Crop Science 2026 Portfolio and R&D | We are streamlining our portfolio and adjusting our R&D footprint cEBITDA impact by '29 from R&D measures1 >€150m Maximized return on innovation Improved innovation efficiency Reduced R&D (fixed) costs 1. Impact from R&D initiative only; does not include negative gross profit impact of divestments and portfolio pruning 2. Also divested Iprovalicarb, Ethoxysulfuron, and Triadimenol Note: AI = Active Ingredient, SPG = Strategic Product Group, defining a specific formulation in a particular geography Our 2029 ambition /// Bayer Crop Science 2026 Progress towards 2029 ambition Divested five non-strategic AIs (e.g., Flubendiamide and Metribuzin2) Conducted pruning of >100 margin dilutive, non-strategic products Refined pipeline steering to sharpen financial prioritization criteria Started consolidation of R&D footprint and capacity streamlining Rolled out efficiency measures incl. agentic automation Initiative Portfolio review & streamlining R&D innovation & footprint optimization 105 2026 2027 2028 2029 ~200 Discontinued SPGs (cumulative, #) ~40 2026 2027 2028 2029 >150 Run rate cEBITDA impact (€m) On track On track 26
Page 27
27 /// Bayer Crop Science 2026 Efficiency measures and site consolidation are progressing well Global R&D footprint adjustments (examples)Progress towards 2029 ambition Decided rightsizing of R&D capacity, incl. site consolidation and network optimization Defined perimeter for localization of activities and target locations for cost advantages Adjusted pipeline assessment framework, setting higher financial thresholds for new projects Discontinued R&D and regulatory activities in first wave of 10+ "Harvest" countries Introduced agentic automation at scale to increase efficiency and time to market Localization of activities Transfer activities from high— wage to best cost countries Increase market proximity & tap into global talent pool Example: CP Formulation Tech. Center in Yuki, Japan Re-location from Yuki to other countries (e.g., India) Closure of CP Center in Yuki Site consolidation Reduce fixed site cost through closures Gain efficiency of shared assets (analytics, greenhouse) Example: Herbicide R&D in Frankfurt Transfer herbicide research from Frankfurt to Monheim Closure of Frankfurt site R&D innovation & footprint optimization |
Page 28
28 /// Bayer Crop Science 2026 GTM & Global functions (SG&A) | We are adjusting our GTM & global function setup >€400m Our 2029 ambition cEBITDA impact by '29 from SG&A measures Improved gross-to-net1 realization Reduced cost-to-serve Prioritized resource allocation 1. Gross-to-net refers to difference between gross and net revenue due to market funding ( discounts, rebates, returns, and other deductions) /// Bayer Crop Science 2026 Progress towards 2029 ambition (Run rate cEBITDA impact in €m) Progressed with significant resource streamlining Improved gross-to-net realization via demand generation, channel strategy Implemented country archetype measures (wave 1) Progressing functional productivity programs, incl. automation and AI use on top of completed DSO optimization Reviewed outsourced service and refining SLAs for spend reduction Initiative Go-to-market: Differentiated value-based approach Global functions: Setup adjustment 2026 2027 2028 2029 40 >200 2026 2027 2028 2029 50 >200 On track On track 28
Page 29
29 /// Bayer Crop Science 2026 Strengthened demand generation and gross-to-net realization Streamlined channel partner network to improve cost-to-serve Deep dive GTM | We successfully launched improvement initiatives, implementing our new country archetypes Sales & profit potential2 13 countries 50 countries Remaining countries >70% % Bayer CS sales contrib.1 <25% <5% 1. Based on 2024 baseline (actual net sales) 2. Illustrative profit potential per country 3. Bayer focus brands with high strategic fit for specific country environment, driving growth, such as VayegoTM in Korea, Philippines and Vietnam; Velum in Vietnam and Japan Progress so far ......... Increased collaboration with stra- tegic partners (distributor, retailer) Sharpened strategic focus on Mission Brands3 Changed from own team to distribution model Discontinued commercial activities in wave 1 countries "Leverage" countries "Harvest" countries Increase proximity to farmer Optimize cost-to-serve Free up resources -€30m p.a. -100 FTEs "Focus" countries x Achievements so far ... Next steps Expand on-farm presence Further refine channel partner network Drive digital demand generation Further refine channel partner approach Continue review of GTM model fit Prepare transition to distribution model for further markets ~10 countries discontinued in wave 1
Page 30
30 /// Bayer Crop Science 2026 Cash flow | We are ahead of schedule to deliver >€1.5bn incremental cash Our 2029 ambition Cumulative cash freed from working capital '24-'291 >€1.5bn Increased cash focus in decisions Lower working capital need Proactive mgmt. of seasonality 1. Cumulative cash impact '24-'29, incrementally on top of cEBITDA effect, at constant currency; Note: AI = Active Ingredient /// Bayer Crop Science 2026 Progress towards 2029 ambition Initiative Supplier cash On track Improved payment terms for supplier cash Re-negotiated top-200+ suppliers Extended usage of supply chain financing Set up Mission Team to intensify focus +4 days Extended supplier payment terms ('25 vs. '24) Inventory Ahead of schedule Reduced inventory by €500m in 2025 already Prioritized stock level for global AIs Reduced regional inventory of formulated products and seeds €500m Inventory reduction in 2025 30 Reduced Days Sales Outstanding Standardized payment terms and fostered timely collection Expanded price-linked terms to Asia Customer cash On track -2 days Sales outstanding reduction ('25 vs. '24)
Page 31
31 /// Bayer Crop Science 2026 Capitalize pipeline value | Progressing on our platform strategies Other S&T Soy S&T Corn S&T Strengthen the foundation GTM & Global functions Product supply Portfolio & R&D Cash Core CP Expand beyond the Core Biological solutions Biofuel seeds Hybrid wheat Non-Core CP Capitalize pipeline value in Core Corn: Set up continued momentum with 13% YoY growth in 2025 and double digit growth in all regions; strong progress of innovation launches1 Soy: Stabilized topline by regaining dicamba label in NA and growing market share of Intacta 2 Xtend® in Brazil by 9%-pt.2 Other S&T: Achieved market share gains in all crops based on strong portfolio and focused GTM measures (e.g., ~+8%-pt. in Canola in 2026)3 Core CP: Progressed blockbuster launches while expanding proven solutions in LCM to new crops, applications, and geographies4 Non-Core CP: Ruveon is a distinctly managed business for US Glyphosate5 Note: AI = Active Ingredient
Page 32
32 /// Bayer Crop Science 2026 Drive profitable growth via targeted R&D and focused GTM Low single digit growth Core CP (HER, FUN, INS) Optimize operations for efficiency via ultra-lean, dedicated business model Non-core CP (incl. Ruveon1) cEBITDA margin focus Soy (Seeds & Traits) Defend acreage share and prepare innovation-driven growth for 2028+ Essentially flat Other S&T (Cotton, Canola, Veg) Expand market share via innovation & commercial reach Mid single digit growth Corn (Seeds & Traits) Strengthen #1 position via innovation, geographic expansion, and GTM Mid single digit growth Net sales CAGR (cpa3) until '29: Based on our differentiated steering by platform, we drive topline growth through 2029 25A 27F 29F 34F 25A 27F 29F 34F 25A 27F 29F 34F25A 27F 29F 34F 25A 27F 29F 34F Topline moving in line with Gly price development 1. US Glyphosate business as by announcement from 07/01/26 2. This product is not currently available for commercial sale or commercial planting. Commercialization is dependent on multiple factors, including successful conclusion of the regulatory process. The information presented herein is provided for educational purposes only, and is not and shall not be construed as an offer to sell. 3. Currency- and portfolio-adjusted Growth after VyconicTM2 and Intacta 5+ launches
Page 33
33 /// Bayer Crop Science 2026 Our innovation pipeline for the next years Innovation engine | Our pipeline unlocks the next wave of innovation in agriculture, ensuring achievement of our ambition Breeding advancements and germplasm updates, >400 new hybrids and varietal launches p.a. Breeding and germplasm S&T geo expansions to emerging seeds and traits markets in Asia and Africa S&T geo expansion CP formulation innovations and lifecycle managementCP LCM Strongest trait and CP AI pipeline in industry Icafolin Blockbusters LEP4 CRW4 New Fungicide Net sales until 2035+ 2024F 2025F 2027F 2029F 2031F 2033F 2035F+ 1. Expected net sales generated from innovations, including incremental growth sales and replacement/refresh of portfolio (e. g., new generations) Note: VyconicTM is not currently available for commercial sale or commercial planting. Commercialization is dependent on multiple factors, in cluding successful conclusion of the regulatory process. The information presented herein is provided for educational purposes only, and is not and shall not be construed as an offer to sell. The Preceon Smart Corn System, including short stature corn products developed through traditional breeding, is commercially available fo r planting in the 2026 growing season through a Preceon Certified Advisor. Net sales from innovations1 Net sales from existing product portfolio Indicative Blockbusters S&T genetics CP LCM GTM + geo expansion Above market CAGR
Page 34
34 /// Bayer Crop Science 2026 Corn | We strengthen our #1 position via trait & genetic innovations, geo expansion, and scale-up of PreceonTM Smart Corn System /// Bayer Crop Science 2026 2025A 2027F 2029F 2034F Platform development (Net sales 2025-34) 34 Corn Mid single digit growth 4 levers to secure and expand our market position Increase genetic market share and launch next-gen traits in NA and LATAM Expand #1 genetics position via ~200 new hybrids annually Launch next-gen trait blockbusters like CRW4 and LEP4 Accelerate geographic expansion in EMEA and Asia Expand EMEA market share by unlocking silage opportunities in Europe and expanding biotech traits in Africa Pursue trait approvals in Asia to further increase market share 1 2 3 Scale up PreceonTM (incl. FieldViewTM) Commercialize PreceonTM at scale globally Further embed FieldViewTM into work of sales force to accelerate grower adoption 4 Increase grower interaction and customer experience Provide best-in-class support to growers, enable their success & increase loyalty 1. Currency- and portfolio-adjusted Note: The Preceon Smart Corn System, including short stature corn products developed through traditional breeding, is commercially available for planting in the 2026 growing season through a Preceon Certified Advisor. Net sales CAGR (cpa1) until 2029
Page 35
35 /// Bayer Crop Science 2026 Geographic expansion | Our Asia and EMEA expansion is making strong progress 1. Currency- and portfolio-adjusted Note: The Preceon Smart Corn System, including short stature corn products developed through traditional breeding, is commercially available fo r planting in the 2026 growing season through a Preceon Certified Advisor. Corn Keep growing in attractive value pools >10% Net sales CAGR (cpa1) until 29 in Asia and EMEA >€600m Incremental sales ambition by 2029 in Asia and EMEA Asia EMEA Double digit growth1 driven by: Existing traits in newly deregulated markets (e.g., Pakistan, Indonesia) BCS germplasm base and breeding capabilities accelerating seed market share in Southeast Asia and India High single digit growth1 driven by: Expansion of existing biotech traits (i.e., VT Double PRO® and Trecepta ®) in Sub-Saharan Africa to leapfrog grower benefit Growth in PreceonTM silage corn throughout Europe /// Bayer Crop Science 2026 35
Page 36
36 /// Bayer Crop Science 2026 Innovation | We are expanding our leading positions with blockbusters, best-in-class germplasm and breeding capabilities Corn 20282026 20352032 Additional weed control options for corn Next-level protection against lepidopteran pests 1. 70% of 2026 commercial hybrid portfolio will be renewed in the market Note: LEP4/5 = 4th and 5th generation Lepidoptera Protection; CRW4 = 4th generation Corn Rootworm Protection; HT5 = 5th gener ation Herbicide Tolerance adding PPO, Timing of launches anticipated, pending regulatory approvals. The Preceon Smart Corn System, including short stature corn products developed through traditional breeding, is commercially available fo r planting in the 2026 growing season through a Preceon Certified Advisor. Preceon Smart Corn System hybrids, developed through biotechnology, are not currently available for commercial sale or commercial planting. Commerciali zation is dependent on multiple factor. Protection against high-pressure rootworm populations Enhanced stress tolerance, higher yield potential Enhanced protection against lepidopteran pests in LATAM [Picture to be added] New hybrids deployed annually >1,000 Genetic improvements – example NA Mid- to long-term trait innovationsShort-term focus … LEP4 CRW4 HT5 LEP5 ~200 Corn hybrids currently in the market ~70% Renewal rate by 20291 2-4% Yield advantage of new launch classes … … First products launched, portfolio expansion with GE & biotech* introduction by 2029+ *In collaboration with Anticipated market introductions
Page 37
37 /// Bayer Crop Science 2026 | Our PreceonTM Smart Corn System already revolutionizes corn growing and demonstrates steady achievements /// Bayer Crop Science 202637 Corn Improved yield potential, resilience, and protection from lodging & greensnap Short stature corn products Extended field access & increased flexibility for late- season crop protection application Input optimization Maximized performance via data- driven guidance & FieldViewTM tracking Digital experience Customized support for farmers provided by our salesforce and distributors Tailored support Participating acreage in our Ground Breakers® Program triples every year1, exceeding our roadmap targets First commercial launches in Europe (Spain & Italy) capturing 5% of silage segment in first year2 Global PreceonTM launch approach Commercial launch Ground Breakers® trials Commercial sales 4 years prior commercial launch Illustrative share of market penetration during Ground Breakers ® trials (% of addressable market) Brazil, Argentina and further EMEA countries Vitala and PreceonTM Program 1. 2024-2026 period 2. By volume, in 2026 Note: The Preceon Smart Corn System, including short stature corn products developed through traditional breeding, is commercially available fo r planting in the 2026 growing season through a Preceon Certified Advisor. Illustrative share of market penetration during commercial introduction (% of addressable market)
Page 38
38 /// Bayer Crop Science 2026 | We are committed to expanding our coverage to 26m acres globally by 2035 PreceonTM corn portfolio, m acres Corn PreceonTM will strongly further improve our corn platform performance Gaining higher value per acre Seed value per acre for PreceonTM is at least 10% higher compared to traditional tall corn Capturing market share from competition With PreceonTM Smart Corn products stacked with other corn technologies, we will capture additional acreage Creating system advantage Additional upsides for fungicides from possibility of late-season spraying applications FUN enablement >10% sales uplift per acre 0 5 26 50 2025 2030 2035 2040 38 acreage share gain by 2035 4%-pt. Note: The Preceon Smart Corn System, including short stature corn products developed through traditional breeding, is commercially available for planting in the 2026 growing season through a Preceon Certified Advisor. /// Bayer Crop Science 2026
Page 39
39 /// Bayer Crop Science 2026 Soy | We have laid the foundation to drive long-term growth in key markets with our upcoming innovation /// Bayer Crop Science 202639 1. Currency- and portfolio-adjusted 2. This product is not currently available for commercial sale or commercial planting. Commercialization is dependent on multiple factors, including successful conclusion of the regulatory process. The information presented herein is provided for educational purposes only, and is not and shall not be construed as an offer to sell. 2025A 2027F 2029F 2034F Soy Essentially flat Positioning in key soy markets US: Delivered short-term objectives to secure market position Gained dicamba re-registration for 2026 and 2027 growing seasons Defended soy acre share and stabilized topline through GTM campaigns Streamlined cost structure to increase profitability (e.g., Windfall site divestment) Prepared limited commercial launch of VyconicTM2 in Asgrow and Channel brands in 2027, with large scale launch across owned and licensee partner brands for 2028 growing season LATAM: Secured market share for the mid-term growth Increased market share of Intacta 2 Xtend® by 9%-pt. to ~30% in 2025 as part of conversion program from predecessor trait (Intacta RR2 PRO®) Prepared launch of Intacta 5+® to seed multipliers for 20272, enabling commercial sales in 2028 growing season Growth after VyconicTM2 and Intacta 5+ launches Platform development (Net sales 2025-34) Net sales CAGR (cpa1) until 2029
Page 40
40 /// Bayer Crop Science 2026 Delivered our short-term targets NA | We hit our short-term goals and are ready to introduce VyconicTM to re-gain market leadership Vyconic 1 introduction Soy Industry-first trait package with tolerance to 5 herbicides and game changer for soy production as it allows farmers to shift focus from weed control to yield performance #1 Yield advantage of Bayer Vyconic 2027 class against Enlist E3® soybeans2 Obtained dicamba re-registration in 2026 Re-gained EPA label in Feb 2026 Launched Stryax herbicide Aggressively defended share of acres Promoted Asgrow & Channel brands based on yield advantage Achieved market share stabilization in HY1 2026 Streamlined cost structure, reduced fixed costs Divested processing facility in Windfall, IN Increased efficiency of seed production (e.g., decreased per unit handling cost by 12% in US) Genetic improvements 2027: Limited launch to Asgrow and Channel brands 2028: Full-scale commercial launch 2032: Ambition for >50% trait share 2.2 bu/ac Genetic footprint by 2029 capturing market share with our high performing varieties 1. This product is not currently available for commercial sale or commercial planting. Commercialization is dependent on multiple factors, including successful conclusion of the regulatory process. The information presented herein is provided for educational purposes only, and is not and shall not be construed as an offer to sell. Pending applicable regulatory approvals. 2. Bayer germplasm trials in 2025. 12,324 head-to-head comparisons of Bayer’s Vyconic soybeans (Asgrow® brand, Channel® brand, and licensee varieties) vs. key Enlist E3® soybean checks in major soybean growing regions. +/ - 0.2 RM. 61% win rate. Timeline
Page 41
41 /// Bayer Crop Science 2026 LATAM | With our next-gen trait launches and high-yielding genetics, we are set to expand our market position 1. These products are not currently available for commercial sale or commercial planting. Commercialization is dependent on multiple factors, including successful conclusion of the regulatory process. The information presented herein is provided for educational purposes only, and is not and shall not be construed as an offer to sell. 3. Moderate protection against Spodoptera cosmioides and Spodoptera eridania 2. 0-100 score, function of application effectiveness and coverage of relevant weed species (12 target species in total) 4. Int acta 5+: All Bayer (Monsoy, Agroeste, Licensee) vs All Conkesta Enlist season 2025/2026 Brazil, Data using +0.2/-0.2 day RM difference, 68% win rate and 11,869 comparisons Note: IP = Insect Protection Intacta 5+® with superior insect protection from IP3 technology and unmatched weed control of 4th gen HT trait1 Soy We successfully manage transition to Weed effective coverage2 68 75 100 Next best competitor Genetic improvements Progress of our short-term priority Mid-term topline growth with Intacta 5+ ®1 Peak sales; post 2028 shift to next gen trait Controlled pests Next best competitor yield advantage vs. competitors at comparable maturity4 Growth of Bayer genetic footprint until 2030 Basis: 12 most critical weeds 5+23 6 9 23/24 24/25 25/26 26/27P 27/28P 9% 19% 28% >65%+9%-pt. Intacta 2 Xtend® market share development (%) Timeline On track 4.3 bu/ac 2x Continued our transition from Intacta RR2 PRO® to the next generation Intacta 2 Xtend® Outperformed next best competitor trait in 2025 Precision breeding drives expansion of genetic gain
Page 42
42 /// Bayer Crop Science 2026 Growth aspirations and drivers by crop Other Seeds & Traits | We are also growing in other attractive crops, leveraging our strong R&D capabilities and commercial reach /// Bayer Crop Science 2026 2025A 2027F 2029F 2034F 42 1. Currency- and portfolio-adjusted 2. Pending regulatory approvals. These products are not currently available for commercial sale or commercial planting. Commercialization is dependent on multiple factors, including successful conclusion of the regulatory process. The information presented herein is provided for educational purposes only, and is not and shall not be construed as an offer to sell. Other S&T Mid single digit growth Canola: Expand market share Launch next-gen hybrids with excellent yield performance to fuel our low double digit sales growth ambition until 2029 Deploy region-specific GTM tactics to promote fast adoption of new products Cotton: Maintain and fortify #1 market position Launch next-gen Bollgard4TM & HT4 traits2 Implement country-specific strategies to achieve mid single digit sales growth ambition until 2029 Vegetables: Gain market share and become global #1 Refresh portfolio with 400+ new and differentiated varieties to deliver ambition of mid single digit sales growth ambition until 2029 Realize benefits from R&D investments, e.g., in genome editing to further set our portfolio apart in the mid- to long-term Platform development (Net sales 2025-34) Net sales CAGR (cpa1) until 2029
Page 43
43 /// Bayer Crop Science 2026 Europe DEKALB® variety traits, such as resistance against TuYV3, enabling yield resilience Canada New launch class delivers 3.4 bu/ac. (>6%) yield advan- tage vs. #1 competitor's2 hybrid Canola | Our actions will enable double digit growth through 2029 We will grow our market share with our differentiated, high performing genetics and regional growth initiativesCanola / OSR ambition (net sales 2025-34) Other S&T Global Canola / OSR market expected to grow at 1-2% CAGR over next decade driven by biofuel and food demand1 Precision Breeding driving superior genetic gains and faster time to market /// Bayer Crop Science 202643 Region-specific strategies for operationalization of growth 1. OECD-FAO Agricultural Outlook 2026-2035. 2. DEKALB DK401TL compared to InVigor® L340PC, L356PC, and LR354PC, 2023-2025 Bayer Market Development Trials. DEKALB DK401TL compared to InVigor® L330PC in 2025 Bayer Market Development trials. Moisture adjusted, before dockage, non -replicated, large-scale trials. Standardized weight of 50 lbs./bu. at 9% moisture for one bushel of canola. Win % is the % of individual locations where DK401TL had a higher yield than the comparison product. Your results may vary depending on agronomic and environmental conditions and management decisions. InVigor® is a registered trademark of BASF, used under license by BASF Canada Inc. Note: OSR = Oilseed rape 2025A 2029F 2034F2027F Selected examples Low double digit growth Net sales CAGR (cpa1) until 2029
Page 44
44 /// Bayer Crop Science 2026 Cotton | We further fortify our #1 position in Cotton through trait leadership and strong region-specific strategies Other S&T globally1 in Cotton S&T#1 Cotton ambition (net sales 2025-34) Global cotton mill demand growing at ~2% CAGR over the next decade2 Expand trait leadership through ThryvOn® adoption and launch of next-gen BG4 & HT43 in 2029 Region-specific strategies for operationalization of growth Australia Expanding share of acreage and launching ThryvOn® trait technology USA Expanding trait and germplasm advantage in our own brands and growing trait licensing share in global1 trait market /// Bayer Crop Science 202644 Our trait innovation and regional strategies will enable us to benefit from market growth and further gain share 2025A 2029F 2034F2027F 1. Data available for US, Brazil, and Australia 2. OECD-FAO Agricultural Outlook 2026-2035. 3. Pending regulatory approvals. These products are not currently available for commercial sale or commercial planting. Commercialization is dependent on multiple factors, including successful conclusion of the regulatory process. The information presented herein is provided for educational purposes only, and is not and shall not be construed as an offer to sell. >60% Brazil Growing trait share with industry-leading traits through licensing and Deltapine® brand Selected examples Mid single digit growth Net sales CAGR (cpa1) until 2029
Page 45
45 /// Bayer Crop Science 2026 Vegetable seeds | With our pipeline, we are set to outgrow the market and deliver mid single digit growth through 2029 Other S&T Global vegetable seed market estimated to grow at ~2% CAGR over 5-year period 2025-2029 /// Bayer Crop Science 202645 Our advanced innovations and differentiated pipeline will lead us to the #1 Veg seed market positionposition in tomatoes & peppers, 2 of top-3 veg crops#1 global market position in vegetable seeds#2 2025A 2029F 2034F2027F Vegetable ambition (net sales 2025-34) 1. Tomato Brown Rugose Fruit Virus 2. These products are not currently available for commercial sale or commercial planting. Commercialization is dependent on multiple factors, including successful conclusion of the regulatory process. The information presented herein is provided for educational purposes only, and is not and shall not be construed as an offer to sell. Note: NVI = New variety introductions We deploy market leading breeding capabilities and will leverage Genome Editing to enhance our pipeline 400+ NVIs in 2026-30 2026: Fusarium resistant cucumber 2028: ToBRFV1 high resistance tomato2 2029: Vitamin D tomato (gene-editing)2 Selected examples Launch our strong pipeline of highly differentiated products with breakthrough innovations Mid single digit growth Net sales CAGR (cpa1) until 2029
Page 46
46 /// Bayer Crop Science 2026 Core CP | We drive the launch of our blockbusters, upgrade our portfolio through LCM, and focus GTM on high-margin opportunities /// Bayer Crop Science 2026 2025A 2027F 2029F 2034F 46 1. Currency- and portfolio-adjusted Core CP Low single digit growth 3 levers to secure profitable growth Further progressed launch of new AI blockbusters Obtained first PlenexosTM registrations – launches in >30 countries by 2029 Planned >95% dossier submissions for Icafolin registration by end of 2026 Started preparation of dossier submission for New Fungicide in 2027 Focused Lifecycle Management (LCM) on high value opportunities Leveraged proven solutions to expand market share Implemented priority LCM initiatives to grow, e.g., ConvintroTM geographic expansion to US and Brazil; VayegoTM crop & application expansion; FoxTM brand evolution Progressed GTM changes to increase customer proximity Actively re-deployed resources from "Harvest" to "Focus" markets Focused commercial teams on growth products ("Mission Brands") Refined channel structure and intensified retail partnerships 1 2 3 Platform development (Net sales 2025-34) Net sales CAGR (cpa1) until 2029
Page 47
47 /// Bayer Crop Science 2026 40+ Blockbusters | We are on track to launch our blockbusters, addressing a broad range of farmer needs in major markets Core CP Launches of two blockbuster AIs until 2029 Icafolin dossier submission progress, % market potential Launch plan on track, registrations in major INS markets expected in 26/27 Commercial ramp-up foresees peak sales potential of €500m in mid-2030s Registration process on track – 95% of relevant dossiers will be submitted by end '26 Commercial launch plan, incl. add. HT opportunities (HT6), targeting €750m sales potential Icafolin 15% >80% <5% Submitted Submission in 2026 Submission in 2027 and beyond 50+ countries in total Innovation launches 1 2030+ New FUN 10 14 11 2026-27 2028-29 2030-31 Mid-2030s Total launches by mid-30s 70+ First wave of registrations, anticipated in 2028/29, includes Australia, Brazil1, Colombia, Canada, US, and several Asian countries INS HER PlenexosTM launch plan, # countries +… +… +… On track On track On track 1. First wave – AI fast track registration Registration submissions starting in 2027 with first commercial launches in 2030s To be started Targeting >€6bn addressable market
Page 48
48 /// Bayer Crop Science 2026 QUICK Core CP Focus LCM 2 Lifecycle management (LCM) | We expand our proven solutions across geographies, crops, and applications 1. Total harvested area for autumn-sown cereals in 2024 for the EU-27; total harvested area for soy and corn in Brazil and US Source: Copa Cogeca, internal data Rising weed resistances to established herbicide modes of action open opportunities in new markets for various crops New formulations to build strong brand family targeting new segments Geographical expansion Targeted crop & spectrum expansion Evolution of FoxTM brand by adding Inpyrfluxam to improve efficacy and break resistance in treating Asian Soybean Rust & related diseases Brand expansion Selected examples >35m Current EU markets >100m New markets ha addressable land1 Targeted pests Pest expansion QUICK Crop expansion Stem borer Sucking & chewing Fall armyworm + Stink-bug Targeted crops (examples) Brand family HER FUN INS 2019 2023 2026 48 Renewing active-ingredient mix in each generation Rice Eggplant Corn Cotton additional
Page 49
49 /// Bayer Crop Science 2026 Non-core CP incl. Ruveon | Unlocking full potential through a lean, dedicated business, built to compete in a commodity market Non-core CP Strategic rationale Commoditized market demands a different playbook Differentiated steering with lean and agile model Dedicated team Fully focused leadership and organization Commodity mindset Culture and KPIs anchored on cost efficiency, throughput, and market responsiveness rather than R&D cycles or premium positioning Volume focus & dynamic pricing Optimized for share growth in target segments with high pricing flexibility, enabling high asset utilization as key margin driver Lean management and support structure Streamlined cost base with minimal corporate overhead; service agreements for transitional functions, built for operational independence GLY competes on cost Scale and dynamic pricing are key Spot market with limited cross-selling potential Structurally competitive, profitable GLY business, with a clear path to sustainable value creation Ruveon enables purpose-built, focused steering Dedicated management team and lean structure Different capabilities and mindset Separate contracts with customers /// Bayer Crop Science 202649
Page 50
50 /// Bayer Crop Science 2026 Other S&T Soy S&T Corn S&T Strengthen the foundation GTM & Global functions Product supply Portfolio & R&D Cash Core CP Expand beyond the Core Biological solutions Biofuel seeds Hybrid wheat Non-Core CP Capitalize pipeline value in Core We are systematically building a market-leading position in new value pools, leveraging our R&D capabilities 1 In new biofuel crops, we are working towards global leadership, securing our position through partnership strategy2 In biologicals, we are expanding our portfolio and increasing our market share through partnership strategy3 Expand beyond the Core | Strategic direction for New Value Pools
Page 51
51 /// Bayer Crop Science 2026 Development of global biofuel demand, bn gallons Biofuel | We are a global leader in new biofuel crops, securing our position through strategic partnerships Our positioning High-yielding portfolio of lower-carbon intermediate crop seeds for biofuels Leverage full R&D capabilities to enhance crop performance Flexible portfolio for geographical fit and scalable supply Our partnerships and brands CoverCress Farm-to-fuel supply chain (Bayer CS with 65% ownership) Camelina Long term strategic alliance to scale up camelina Winter Canola Commercial collabora- tion with SAF market leader in Europe 51 /// Bayer Crop Science 2026 Our ambition Expand our acreage by 60x to >5m acres by 2035 to deliver on unmet demand Commercialization via seed sales and additional downstream value sharing Note: SAF = Sustainable Aviation Fuel Source: S&P Global Energy 2026 26 30 30 29 13 15 17 17 9 9 9 7 11 X Axis 15 2025 3 2030 2035 2040 45 57 63 66 SAF Renewable Diesel Biodiesel Bioethanol Focus for intermediate oilseed crops Addressed with corn, soy & canola/OSR crop innovation
Page 52
/// Bayer Crop Science 202652 Financial Outlook Path to our 2029 Ambition
Page 53
53 /// Bayer Crop Science 2026 We confirm our ambition for above market growth and mid-20% cEBITDA margin by end of the decade Recap CMU 2025 Mid-20% cEBITDA Margin by 2029 Resilient & Flexible Steering • Core Business steered along all elements of the triangle: growth, margin, and cash, in alignment with new operating model • Glyphosate with adjusted model run as distinctly managed business cEBITDA Margin (before special items, incl. Glyphosate): • Annual margin expansion of 100-150 bps on average through 2029, with front end driven by productivity improvements and back end driven by advancing top-line Net Sales: • Expected to grow above market, fueled by innovation Mid-term Ambition (end of decade) Above Market Growth Established in July '26
Page 54
54 /// Bayer Crop Science 2026 Sales | We drive above market growth through 2029 Net sales (cpa1) outlook for 2029, in bn€ 2025A Corn Soy Other S&T CP Non-core CP (incl. Ruveon) 5YF 2029 21.6 Above market growth (~3% vs. ~2% market)1 Low single digit growth cEBITDA focus Essentially flat Mid single digit growth Mid single digit growth 1. Portfolio adjusted and at constant FX /// Bayer Crop Science 202654 S&T New hybrids and genetics (pricing and share gain) Corn geo expansion to Asia and EMEA Blockbusters still in early ramp-up with >€700m contribution; mainly unlocking growth in 2030s CP Lifecycle mgmt. to expand application of existing product GTM adjustments, unlocking potential of Mission Brands Blockbusters in early ramp-up - Plenexos and Icafolin already with contribution; New Fungicide comes post '29 Key drivers of growth Net sales CAGR (cpa1) until 2029
Page 55
55 /// Bayer Crop Science 2026 Licensing revenues | We lead in commercial traits and generate reliable royalty income Closest competitor 5 7 2 4 ~2x Undisputed global trait leadership – #1 trait market share in corn, soy, cotton 2-3 trait generations ahead vs competitors – we work on Gen 5/6 vs. Gen 2/32 Commercial trait launches and pipeline vs closest competitor1 In recent years, >€2.5bn sales from licensing translating into >2bn net licensing income per year through trait and genetics out-licensing Key pipeline trait license arrangements secured, incl.: HT4 in soy and cotton CRW4 and LEP4 in corn High confidence for net licensing income >€2bn p.a. until 2030 with additional growth potential thereafter Resilient licensing income 55 /// Bayer Crop Science 2026 1. As per Science, Competitor, and IP Intelligence (SCIPI) 2. Closest competitor works on generation 2 -3 3. Here a trait event: event may have one or more genes, which each confer specific traits, or characteristics, to the crop >€2bn ~ -€0.2bn Number of traits3 (#) Net licensing income/expense (€bn) Today Total by late 2030s Launch by 2029 Commercial today Launch in 2030+
Page 56
56 /// Bayer Crop Science 2026 2025A 2026F Inflation Growth1 R&D COGS SG&A Other2 2029F 19.4% 20%-22% guidance cEBITDA margin 2025-29, at constant currency in % Accelerating high-margin growth Margin accretive portfolio mix Favorable price and share gains Blockbuster launches Executing margin initiatives of Five-Year Framework CP portfolio pruning COGS, R&D, and SG&A improvements 1. Includes negative gross profit impact of divestments and portfolio pruning 2. Normalization of short -term incentives and one-time effects Margin | We confirm our 2026 cEBITDA margin guidance and mid-term outlook Mid-20s19.4% cEBITDA margin 56 /// Bayer Crop Science 2026
Page 57
57 /// Bayer Crop Science 2026 Cash | We drive further cash productivity and generate >€3bn cash flow by 2029 Free Operating Cash Flow (FOCF) 2025-29, at constant currency in €bn1 1. Includes leasing payments and cost of legal defense, excludes settlements 2025A 2026F 2027F 2028F 2029F >3.0 1.4 57 /// Bayer Crop Science 2026 2025 FOCF impacted by FX headwinds Change in pre-collection practice Cash program >€3bn target for 2029 confirmed based on Profit expansion Working capital and cash conversion >50% cash conversion ambition
Page 58
58 /// Bayer Crop Science 2026 Capital allocation priorities | We prioritize investments in line with our differentiated strategies by platform S&T (Corn, Soy, Other S&T) Strategic directionPlatform Core CP (HER, FUN, INS) Non-Core CP (incl. Ruveon1) Investment priority 1. US Glyphosate business as per announcement from 07/01/26 /// Bayer Crop Science 202658 Continue investment in technology to expand market leadership R&D for genetic & trait leadership CapEx for growth and footprint expansion Optimize GTM and R&D to drive profitable growth R&D for long-term AI pipeline + LCM Process improvement, R&D site adjustments Capital allocation within Ruveon, independent from the core Maintaining asset base
Page 59
59 /// Bayer Crop Science 2026 Key messages for you to take away /// Bayer Crop Science 202659 Five-Year Framework delivery fully on track Measures across all 3 elements of the triangle on track or ahead of schedule Differentiated steering approach across our platforms Enabling our businesses to respond flexibly to market trends Corn is our main growth driver Market share gain from new hybrids and geographical expansion; Preceon 1 will be a leading platform in the next decade Soybean recovery is building strong momentum Vyconic 2 and Intacta 5+® traits poised to lead markets in US and Brazil We are the innovation leader Broadest pipeline and strongest technology capabilities in the industry, fueling our platforms and licensing opportunities 1 2 3 4 6 5 Core CP is being transformed into a leaner business Shifting focus towards profitable growth starts to pay off 1. The Preceon Smart Corn System, including short stature corn products developed through traditional breeding, is commercially available fo r planting in the 2026 growing season through a Preceon Certified Advisor. 2. Pending label approval. This product is not currently available for commercial sale or commercial plant ing. Commercialization is dependent on multiple factors, including successful conclusion of the regulatory process. The information presented herein is provided for educational purpo ses only, and is not and shall not be construed as an offer to sell. Pending applicable regulatory approvals.
Page 61
61 /// Bayer Crop Science 2026 Legal claims and commercialization statements ALWAYS READ AND FOLLOW PESTICIDE LABEL DIRECTIONS. This material may contain “forward-looking statements” based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at http://www.bayer.com/. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments. These products are not currently available for commercial sale or commercial planting. Commercialization is dependent on multiple factors, including successful conclusion of the regulatory process. The information presented herein is provided for educational purposes only, and is not and shall not be construed as an offer to sell. Bayer is a member of Excellence Through Stewardship® (ETS). Bayer's biotechnology-derived products are commercialized in accordance with ETS Product Launch Stewardship Guidance, and in compliance with Bayer’s Policy for Commercialization of Biotechnology-Derived Plant Products in Commodity Crops. Where applicable, commercialized products have been approved for import into key export markets with functioning regulatory systems. Any crop or material produced from commercialized products can only be exported to, or used, processed or sold in countries where all applicable regulatory approvals have been granted. It is a violation of national and international law to move material containing biotech traits across boundaries into nations where import is not permitted. Growers should talk to their grain handler or product purchaser to confirm their buying position for commercialized products. Excellence Through Stewardship® is a registered trademark of Excellence Through Stewardship. Certain practices may be subject to state acre enrollment limits. The regenerative agriculture program described in this material is subject to the current version of the Bayer Carbon-Smart Practices Master Agreement and attached program terms. The information is to aid in the understanding of the program and does not change or modify the Bayer Carbon-Smart Practices Master Agreement and attached program terms in any way. The Preceon Smart Corn System, including short stature corn products developed through traditional breeding, is commercially available for planting in the 2026 growing season through a Preceon Certified Advisor. Preceon Smart Corn System hybrids, developed through biotechnology, are not currently available for commercial sale or commercial planting. Commercialization is dependent on multiple factors, including successful conclusion of the regulatory process. The information presented herein is provided for educational purposes only, and is not and shall not be construed as an offer to sell. It is a violation of federal and state law to use any pesticide product other than in accordance with its labeling. NOT ALL formulations of glyphosate, dicamba, glufosinate, mesotrione, or 2,4-D are being pursued for regulatory approval for in-crop use with Vyconic Soybeans. ONLY USE FORMULATIONS THAT ARE SPECIFICALLY LABELED FOR SUCH USES AND APPROVED FOR SUCH USE IN THE STATE OF APPLICATION. Contact the U.S. EPA and your state pesticide regulatory agency with any questions about the approval status of herbicide products for in-crop use. See the IRM/Grower Guide for additional information. Always read and follow IRM requirements. B.t. products may not yet be registered in all states. Contact the U.S. EPA and your state pesticide regulatory agency with any questions about the approval status of herbicide products for in-crop use. Performance may vary, from location to location and from year to year, as local growing, soil and environmental conditions may vary. Growers should evaluate data from multiple locations and years whenever possible and should consider the impacts of these conditions on their growing environment. The recommendations in this material are based upon trial observations and feedback received from a limited number of growers and growing environments. These recommendations should be considered as one reference point and should not be substituted for the professional opinion of agronomists, entomologists or other relevant experts evaluating specific conditions. IMPORTANT IRM INFORMATION: Certain products are sold as RIB Complete® corn blend products, and do not require the planting of a structured refuge except in the Cotton-Growing Area where corn earworm is a significant pest. Products sold without refuge in the bag (non-RIB Complete) require the planting of a structured refuge. See the IRM/Grower Guide for additional information. Always read and follow IRM requirements. Roundup Ready® 2 Technology contains genes that confer tolerance to glyphosate. Plants that are not tolerant to glyphosate may be damaged or killed if exposed to those herbicides. Vyconic Soybeans contain genes that confer tolerance to glyphosate, glufosinate, dicamba, mesotrione, or 2,4-D. Plants that are not tolerant to glyphosate, dicamba, glufosinate, mesotrione, or 2,4-D may be damaged or killed if exposed to those herbicides. Contact your seed brand dealer or refer to the Bayer Technology Use Guide for recommended weed control programs. Insect control technology provided by Vip3A is utilized under license from Syngenta Crop Protection AG. TriVolt is a restricted use pesticide. The distribution, sale, or use of an unregistered pesticide is a violation of federal and/or state law and is strictly prohibited. Check with your state department(s) of agriculture, local dealer or representative for the product registration status in your state. Not all products are registered for use in all states and may be subject to use restrictions. Services and products offered by Bayer CropScience LLC, through the FieldView platform, are subject to the customer agreeing to our Terms of Service. Our services provide estimates or recommendations based on models. These do not guarantee results. Consult with your agronomist, commodity broker, or other industry professional before making financial, farming, or risk management decisions. More information at https://www.climate.com/legal/disclaimer. FieldView is a trademark of Bayer Group. Agrisure Viptera® is a registered trademark of a Syngenta group company. Respect the Refuge and Corn Design® is a registered trademark of National Corn Growers Association. Acceleron®, Bayer, Bayer Cross, Convintro , DEKALB®, Delaro®, Ground Breakers®, Preceon , Roundup Ready 2 Technology and Design®, Roundup Ready®, ThryvOn® Technology, Trecepta®, TriVolt , VT Double PRO® and Vyconic are trademarks of Bayer Group. All other trademarks are the property of their respective owners. For additional product information call toll-free 1-866-99-BAYER (1-866-992-2937) or visit our website at www.BayerCropScience.us. Bayer CropScience LLC, 800 North Lindbergh Boulevard, St. Louis, MO 63167. ©2026 Bayer Group. All rights reserved.
Page 62
1 /// Bayer Crop Science 2026 R&D Update Mike Graham, Head of R&D 2nd September 2026 Huxley, IA
Page 63
2 /// Bayer Crop Science 2026 Questions we heard from you and we will answer today /// Bayer Crop Science 20262 Does innovation in agriculture still matter? Relevance Competition Will we win the race to the next disrupting innovations? Race Will our innovation pipeline differentiate us beyond 2030? Return
Page 64
3 /// Bayer Crop Science 2026 0 50 100 150 200 1850 1900 1950 2000 A century of R&D delivered today's yields 1. United States since 1866; NCGA Corn Yield Contest historic data; USDA corn yield statistics ; Tollenaar, M. 1985. ”What is the current upper limit of corn productivity? Today Historic achievements | R&D in agriculture is an unprecedented success story Seeds and Traits Crop Protection Fertilizers Agri Machinery Defines yield and "quality" of the crop Safeguards yield against weeds, pests and diseases Provides nutrients required for the crop to grow Allows field work with high precision & efficiency The levers behind the success Our market Corn grain yield in the USA (bu/ac)1 /// Bayer Crop Science 2026
Page 65
4 /// Bayer Crop Science 2026 1. UNDESA 2024 (United Nations Department of Economic and Social Affairs, Population Division (2024). World Population Prospe cts: The 2024 Revision) 2. Compared to 2025, S&P Global Energy (2026) 3. By 2035, OECD-FAO Agricultural Outlook 2026-35 4. By the end of century, varying by crops. Hultgren et. al, (2025) 5. Heap, Intl. Survey of Herbicide-Resistant Weeds (Global count unique cases, Average annual increase of unique cases 1975 - 2025) 6. FAO Saving our soils by all earthly ways possible Why R&D matter even more going forward | With increasing supply- side risks innovation becomes a necessity to meet growing demand Growing population with +1.5bn people on the planet by 20501 Rising biofuel mandates driving 1.5x demand growth to >65bn gal in 20352 Dietary trends, e.g., 12% meat cosump- tion uplift3 drives feed crops demand 11-25% harvest loss risk from climate change4 >10 new resistant weed cases annually; ~550 recorded to date5 90% of all soils at risk of being degraded by 20506 Constantly growing demand Increasing supply risks Innovation urgently needed to produce more on every acre Increase genetic yield potential | Strengthen yield resilience | Protect effectively against weeds, pests & disease
Page 66
5 /// Bayer Crop Science 2026 WHY WE WIN Our leadership spans the key R&D platforms driving agricultural innovation: Breeding, Biotechnology, Genome Editing, Crop Protection and Data Science We seamlessly integrate and scale next-generation technologies to continuously refresh our industry-leading pipeline tailored to growers' needs We uniquely integrate these platforms to create synergistic systems, delivering novel solutions and grower outcomes that competitors cannot replicate Our proprietary data engine and digital platforms accelerate our entire R&D pipeline, speeding the delivery of value to the farm gate 5 /// Bayer Crop Science 2026 Our world-class R&D team possesses the expertise to not only discover but, critically, to execute and deliver breakthrough products at a global scale Others have pieces – we have the full engine That is why we are entering a new phase of blockbuster launches: more products, better performance, more value for farmers
Page 67
6 /// Bayer Crop Science 2026 Delivering superior solutions for growers Our unique advantage | Bayer is the only company that has the engine to design the future of the acre Genome Editing embedded in our #1 Breeding pipeline Biotech platform protected by over 11k granted patents Precision Breeding combines speed w/ No. 1 germplasm library Molecule Design building on industry-leading target discovery System Design Seeds and Traits Crop Protection Digital Solutions /// Bayer Crop Science 2026 Our four foundational R&D platforms Supercharging Data & AI Engine
Page 68
7 /// Bayer Crop Science 2026 Seeds & Traits Breeding, Biotech, Genome Editing
Page 69
8 /// Bayer Crop Science 2026 R&D objectives in Seeds & Traits | Driving growth and resilience through Seed & Trait innovation Leading S&T tech platforms Tangible farmer benefits Corn Soy Other Increase yield resilience in adverse weather and a changing climate Effective protection against weeds, pests and diseases Increase genetic yield potential Biotech Precision Breeding Genome Editing Data & AI Engine
Page 70
9 /// Bayer Crop Science 2026 Corn: Our largest crop | Extending our global leadership in Corn Note: Market shares and positions calculated based on reported segment sales FY2024 relative to latest internal sell -in market size estimates; in scope for the ranking are all publicly listed companies and private companies with financial disclosures co mparable to publicly listed companies | 1. Globally, 2025, Nine Bayer CS trait events vs. four of key competitor combined in 32 commercialized traits 2 . Bayer commercial and market development trials in 2023-2025 in IA, IL, IN, KS, MI, MN, MO, ND, NE, SD, TN, WI representing top 50% of MY27 volume. Head-to-head comparisons of Bayer hybrids (DEKALB® brand, Channel® brand) vs. key competitor brand checks on like traits, RM dif ference +3/-1, with at least 75 comparisons Unmatched trait portfolio/pipeline 2x the trait traits of the key competitor1 Local performance edge +6.2 bu/ac yield advantage vs. key competitor2 2026 Cornerstones of our Corn leadership Corn market position by region Corn #1 NA #1 LATAM #2 EMEA #1 APAC Largest germplasm base #1 in the key corn producing countries over the globe
Page 71
10 /// Bayer Crop Science 2026 Our Data & AI Engine | Integrating genomic and field data at unprecedented scale >13m Seeds chipped globally1 >4.5m GBS samples globally >7.3m Plots planted with cassettes >10m Plot images collected >250k Decisions by AI per day Transforming data into the next generation of agricultural solutions Data & AI EngineCorn >340m Acres of customer corn data GBS = Genotype by Sequencing (Sequencing –based marker method that delivers genome-wide marker profiles) 1. Crops which are chipped: Corn, Soy, Cotton, Wheat, Melon, Cucumber
Page 72
11 /// Bayer Crop Science 2026 Design driven R&D | Translating farmer P&L into our winning innovation pipeline Systematic assessment – BioEconomic Index (Differentiated by: geography, crop usage, environmental conditions etc.) Hyper-local view of the farmer P&L Yield Price realization Fertilizer cost Crop Protection cost Labor and energy cost Other cost Profit ... McLean County Story County Translating the most impactful farmer profit drivers into actionable R&D product profiles Decrease COGS Improve plant health Improve agronomics Increase performance R&D target product profiles Weighting Data & AI EngineCorn Late 105-110RM US Market
Page 73
12 /// Bayer Crop Science 2026 Precision Breeding pipeline advantage | Accelerating genetic gain >2x, widening our competitive lead Dynamic & non-linear – 5 years to 4 months Continuous Genetic Cycling Product Development 0 50 100 150 200 2020 2022 2024 2026 Genetic gain ($/ac)2 Precision Breeding Historical Breeding New hybrid /// Bayer Crop Science 2026 Enabling 15x faster breeding cycles Precision Breeding approach Unlocking value for our NA growers in late maturities1 Lines & Data Precision BreedingCorn 1. 105-110RM 2. At $3.58 per bu corn price, modeled data ~13 $/ac/a genetic gain2 ~38 $/ac/a genetic gain2
Page 74
13 /// Bayer Crop Science 2026 Digital Field Twin | Slashing time-to-market by predicting performance on every acre Yield simulations to assist product placements Yield simulation across millions of environments First field simulations in product advancement Long-term outcomes Reduced time to market for customers by 1-2 years Increased efficiency in testing our products Transition from 3 physical testing locations to greater than >85,000 simulated data locations across same county Accomplishments Near complete acre coverage in Story County with over 300,000 acres simulated Leveraging our unique Digital Field Twin capabilities Precision BreedingCorn Story County, IA. Full statewide capability scales to 7.6M simulated locations across Iowa
Page 75
14 /// Bayer Crop Science 2026 Our breeding advantage in practice | Recently launched DKC68-35 hybrids in the USA deliver best-in-class value for our growers Corn DKC68-35 Contest winning hybrid Won 67% of 2025 National Corn Yield Contest categories Outperforming with +13 bu/ac yield advantage (82% Win rate) in trials against key competitor1 Leveraging proprietary international genetics from multiple continents (Thailand, Mexico, Argentina, USA) Superior plant and grain characteristics heat & drought tolerance, grain quality and robust root strength Adapted to ~60% of US Corn acres if planted by May 1st United States 1. Bayer germplasm trials in 2023-2025 in L, IN, IA, KS, MI, MN, MO, NE, ND, SD, TN, and WI. Head-to-head comparisons of Bayer hybrids (DEKALB® brand, Channel® brand) vs. key Brevant/Pioneer brand checks on like traits, CM & MD trials (Commercial Trials), RM difference +3/-1, 1,200 comparisons Source: NCGA 2025 Precision Breeding
Page 76
15 /// Bayer Crop Science 2026 The Trait Discovery Platform | An unmatched engine for biotechnology innovation Leading plant, pest & genetic libraries AI-enabled trait design, test & learn Computationally designed gene expression Optimization evaluated in greenhouse Optimization validated in field trials Designing industry-leading trait solutions and maintaining our leadership position /// Bayer Crop Science 2026 BiotechCorn 7x increase in complete genomes 10x Efficiency gains through trait transformation innovation Unique design capability enabling tunability >200x greater target activity than current traits in develop. Double the number of high-value trait products by 2040
Page 77
16 /// Bayer Crop Science 2026 Trait pipeline advantage | We have the strongest trait pipeline in the industry In market To date Key competitor2 Number of traits1 in pipeline vs key competitor (all crops) Market leading Biotech platform /// Bayer Crop Science 2026 5 In launch3 2026-2029 In pipeline4 2030+ Note: Number of traits account for all crops not just Corn. | 1. Referring to trait event: event may have one or more genes, which each confer specific traits, or characteristics, to the crop 2. Publicly communicated pipeline by key competitor 3. Late phase 4 candidates, commercial launch is being prepared (Preceon Biotech, VyconicTM, Intacta 5+, CRW4, LEP4) 4. "In pipeline" describes traits currently in Proof of Concept to (late) development stage (Phase 1-4) 16 Phase I Phase II-IV BiotechCorn >2x >15 Countries reached with our traits #1 Trait share globally in corn, soy, cotton 2-3 Trait generations ahead competitors
Page 78
17 /// Bayer Crop Science 2026 Corn pipeline advantage | Our current and upcoming innovation launches will set new performance standards Our innovations and their yield performance for MY27 Yield delta in bu/ac to key competitors Leveraging our tech platforms Corn MY = Marketing year | 1. Bayer commercial and market development trials in 2023-2025 in IA, IL, IN, KS, MI, MN, MO, ND, NE, SD, TN, WI representing top 50% of MY27 volume. Head-to-head comparisons of Bayer hybrids (DEKALB® brand, Channel® brand) vs. key competitor brand checks on like traits, RM dif ference +3/-1, with at least 75 comparisons 2. Bayer commercial and market development trials in 2024-2025 in CO, DE, GA, IL, IA, IN, KS, KY, MI, MN, MO, NE, NY, OH, PA, TN, W I representing active lifecycle PreceonTM products of MY27 volume. Head-to-head comparisons of Bayer PreceonTM hybrids (DEKALB® brand, Channel® brand) vs. key competitor brand checks, RM difference +3/ -3. Biotech Precision Breeding Genome Editing Data & AI Engine First gene edits commercial by early 2030’s +7.4 bu/ac1 +4.8 bu/ac1 +11.7 bu/ac1 +9.4 bu/ac2 Precision Breeding and Biotech
Page 79
18 /// Bayer Crop Science 2026 A new era in product design | Building a system that competitors cannot replicate Unparallel speed, scale, and increase in performance Unparallel editing scale, target identification, & incorporation to breeding pipeline P A T G C C A A … Genome Editing and 50+ years of functional biology research Precision Breeding and 50+ years of Genetic Research >1000 edits field tested, > 10 edits advancing in pipeline Architecture, agronomics, and pipeline efficiency, eg Short Corn Best in class collaboration including 7 years with Pairwise Biotech, Breeding and Gene Editing form a complete flywheel New disruptive product concepts, e.g. Nitrogen Use Efficiency Competitors have pieces, not the system Made possible now due to advances in data & computing Long-term outcomes Accomplishments Genome EditingCorn
Page 80
19 /// Bayer Crop Science 2026 Genome Editing | A step-change in innovation – Genome Editing to drive up to 100% of our early breeding pipeline Maturity & Tassel Characteristic Photosynthesis & Resilience Ear & Seed Enhancements Leaf and Canopy Architecture Plant Stature Root Morphology and NUE GE unlocks new corn characteristics GE corn in our pipeline Corn Genome Editing NUE = Nitrogen use efficiency 1. Compared to transgenic pipeline Largest introduction of novel variation across corn and soy in history of breeding 10% of the early pipelines in corn and soy will have edits by 2028; 100% by 2035 Early 2030’s, launch of first commercial, genome edited class >50 traits with active edit targets in the pipeline, a 10x increase in trait targets1
Page 81
20 /// Bayer Crop Science 2026 Soy global market leadership | Leading positions in all major soy regions, built on superior genetics and traits #2 NA #1 LATAM Soy trait market positions Our market leadership in soy Best-in-class facilities and a strong portfolio Juana Díaz, Puerto Rico Petrolina, Brazil Superior trait launch pipeline VyconicTM and Intacta 5+ with industry's yield leading genetics Trait advantage >85% trait market share in Brazil Genetic advantage Outstanding 2.2 bu/ac yield potential in VyconicTM 1 Soy Note: Market shares calculated based on reported soybean acres, internal sates data and average planting rates | 1. Pending E PA approval; his product is not currently available for commercial sale or commercial planting. Commercialization is dependent on multiple factors, including successful conclusion of the regulatory process. The information presented herein is provided for educational purposes only, and is not and shall not be construed as an offer to sell. New breeding technologies at scale Increase lines tested by 25x from 2021 to 2025 Ankeny, Iowa
Page 82
21 /// Bayer Crop Science 2026 Soy pipeline advantage | Our upcoming innovation launches will deliver new levels of performance Our innovations and their yield performance Yield delta in bu/ac to key competitors Next-gen insect protection +4.3 bu/ac yield advantage vs. all I2X (all competitors)3 Industry’s first trait stack with tolerance to 5 herbicides4 +2.2 bu/ac yield advantage vs. Enlist E3® soybeans2 Leveraging our tech platforms Insect protection paired with dicamba +2.1 bu/ac yield advantage vs. all I2X (all competitors)1 Soy 1. Intacta XTEND: All Bayer (Monsoy, Agroeste, Licensee) vs I2X, 2026. Data from PCM4 materials using +0.2/ -0.2 day RM difference, 60% win rate and 12,677 comparisons 2. VyconicTM: Bayer germplasm trials in 2025. 12,324 head-to-head comparisons of Bayer’s Vyconic soybeans (Asgrow® brand, Channel® brand, and licensee varieties) vs. key Enlist E3® soybean checks in major soybean growing r egions. +/- 0.2 RM. 61% win rate; pending EPA label approval 3. Intacta 5+: All Bayer ( Monsoy, Agroeste, Licensee) vs All Conkesta Enlist season 2025/2026 Brazil, Data using +0.2/-0.2 day RM difference, 68% win rate and 11,869 comparisons 4. NOT ALL formulations of glyphosate, dicamba, glufosinate, mesotrione, or 2,4-D are being pursued for regulatory approval for in-crop use with Vyconic soybeans. ONLY USE FORMULATIONS THAT ARE SPECIFICALLY LABELED FOR SUCH USES AND APPROVED FOR SUCH USE IN THE STATE OF APPLICATION. It is a viola tion of federal and state law to use any pesticide product other than in accordance with its labeling. Not all application timings may be available at product launch. See final EPA approved label for application rates and timings. Biotech Precision Breeding Genome Editing Data & AI Engine First gene edits commercial by early 2030’s +2.1 bu/ac +2.2 bu/ac +4.3 bu/ac
Page 83
22 /// Bayer Crop Science 2026 Hybrid wheat | We will change the future of the worlds' largest crop Other S&T Leading varieties today, further yield upside from hybrids WestBred leads the 2025 National Wheat Yield Contest We build upon a strong germplasm base, combining the best of three origins. Launch in early 2030s. Building the biggest wheat germplasm base Next best variety WestBred® 125 bu/ac 140 bu/ac Note: Hybrid wheat is not currently available for commercial sale or commercial planting. Commercialization is dependent on m ultiple factors, including successful conclusion of the regulatory process. The information presented herein is provided for edu cational purposes only, and is not and shall not be construed as an offer to sell | 1. Comparison to 3 modern WestBred® commercial varieties (Hard red winter wheat) in TX, KS, NE; 195 hybrids tested, HBULP analysis 2. 16 national winning placem ents out of 28, National Wheat Foundation, 2025 NWYC National Winners New hybrids Hybrid wheat pushes yields beyond leading varieties 2025 hybrid trials vs. modern WestBred varieties1 2025 NWYC, Winter Wheat irrigated Kansas 57%2 of national winning placements Up to +11% yield gain
Page 84
23 /// Bayer Crop Science 2026 Crop Protection
Page 85
24 /// Bayer Crop Science 2026 The CropKey advantage | AI-powered leadership in target discovery and molecule design >4,000x increase in the number of targets available Identification of the target proteins – the lock AI-powered design of the right molecule – the key Safe by Design through predictive & experimental science AI phenotyping of biological performance Prescriptive Synthesis and AI-driven formulation develop. 30,000x increase in biological insights per molecule 5 years earlier safety insights, ensuring 'registrability' 60,000x increase in chemistry spaces 2 years faster product development and time to market Unlocking the most differentiated, resilient and registerable innovations for the benefit of our growers
Page 86
25 /// Bayer Crop Science 2026 A new paradigm in Crop Protection | Leading the industry in Mode of Action discovery Our new strategy - Designing the Best Increasing share of new MoA: >15 new Mode of Actions in pipeline Old industry paradigm Incremental innovation 2000 - Today Today - 2030 2030 - 2040 2040+ The whole industry performed incremental development of new molecules based on the same 8 key MoAs1 Commercial of Development candidates are new MoAs of Research and Early Development candidates are new MoAs of Early Research new chemical classes based on new MoAs X Percentage of new Bayer MoAs (new targets for Phase 0) in respective stage Icafolin of Target Discovery candidates are new molecular targets Anticipated market entry 20% 30% 50% 70% 100% of launched products in the past with new MoA2 Phase III – V Phase I.I – III Phase I Phase 0 20XX - 20XX 1. Majority of CP sales fall on these 8 key MoAs 2. Within the Bayer pipeline
Page 87
26 /// Bayer Crop Science 2026 Proof point – future FUN candidate | A new fungicide designed to outperform in the world's largest fungicide market Efficacy – ASR Fit with chemical regulation Efficacy – Target Spot MoA & Chemistry Exclusivity Environmental Safety Cost of goods Human Safety Safe MoA Superior biological performance with broad spectrum on key, emerging diseases and resistant strains Durable market profile in line with future regulatory focus – Designed to last First-to-market advantage that sets a new industry standard Safe, exclusive and New Mode of Action with proprietary chemistry Our key differentiators Bayer's future ASR fungicide blockbuster Competitor development candidate 1. Soy plots under Asian Soybean Rust disease pressure, comparison of treated with commercial standard product vs new fungicide candidate, tested in 7 locations in Brazil, 2025/26 season | Note: FUN = fungicide; BRA-soy = Brazilian soybean; ASR = Asian soybean rust, commercially relevant in LATAM; planned release of the ASR fungicide in 2035; Environmental & Safety data generated in early development; In development candidate; This product is not currently available for commercial sale or commercial planting. Commercialization is dependent on multiple factors, including successful conclusion of the regulatory process. The information presented herein is provided for educational purposes only, and is not and shall not be construed as an offer to sell. Strengths of our future FUN blockbuster (BRA-Soy) Expected yield advantage with New FUN Soy product concept vs. commercial standard1 +17% (+ 9 bu/ac)
Page 88
27 /// Bayer Crop Science 2026 Biologicals | We use our R&D engine to design next generation Biologicals /// Bayer Crop Science 202627 Our ambition in Biologicals We aim to build a growing and EBITDA accretive Biologicals portfolio We are the partner of choice within the innovation ecosystem Leverage global assets & capabilities Deliver benchmark efficacy/ performance Complementing S&T and CP core business Our portfolio and pipeline Building on proven solutions and globally leading brands Example : Globally leading bio-fungicide Example : Novel biologic bird repellant Our partnerships Selected examples Selected examples >15 projects in pipeline Pest control Disease control Abiotic stress Nitrogen Optimization Biocontrol Biostimulants Biologics are expected to grow by a CAGR of 8% in next ten years Heterogeneous grower needs require specific products for every market Regional product focus for Biologics (exemplary) Source: Global Ag. Biol. Market, Forecast to 2030, Frost & Sullivan, '22 and internal estimates; DunhamTrimmer
Page 89
28 /// Bayer Crop Science 2026 Digital Solutions
Page 90
29 /// Bayer Crop Science 2026 Digital Solutions | AI supercharges how we turn agriculture's largest data ecosystem into value on every acre Unique, unmatched AI-ready data asset Largest set of foundational data3 | Leading AI models and analytics AI-powered insights that drive decisions Open platform, better experience Machine compatibility across all brands | Fits every farming operation | Extensive partner ecosystem +5% (12 bu/ac) yield increase1 +6% (11 bu/ac) yield increase2 x Product use and field management advice to realize top performance 1. Yield increase of Preceon system, including digital recommendation of FieldView; Sample size = 597 farmers, 924 fields, 78 ,000 acres; Product selection recommendations were leveraged on 73% of Preceon fields in 2026, up from 60% in 2025 2. Analysis evaluates differences between two populations: 1635 Valora fields, 1388 control fields, Summer 2025/26 3. >300m ac farm foundation data, largest O mics data and germplasm base; Omics: large-scale analysis of biological molecules and systems, e.g., Genomics, Proteomics, Transcri ptomics x
Page 91
30 /// Bayer Crop Science 2026 System Design
Page 92
31 /// Bayer Crop Science 2026 Exemplary system: HT6-Icafolin | The first weed-control system engineered from the seed onward – a system only we can deliver Up to 25% soy yield increase1 Highly resistance-breaking Over-the-top flexibility with HT system Lower doses – targeted application Creating step-change valueHow each stack contributes to a unique system Crop Protection Digital Solutions Seeds and Traits HT6 trait stacked into elite, best-in- class germplasm Icafolin, a novel active ingredient for the control of resistant grass weeds Field-specific CP recommendations incl. spraying timing and compliance mgmt. With Icafolin-containing product in resistance- challenged environments Note: This product is not currently available for commercial sale or commercial planting. Commercialization is dependent on m ultiple factors, including successful conclusion of the regulatory process. The information presented herein is provided for edu cational purposes only, and is not and shall not be construed as an offer to sell. | 1. Of Icafolin treated soy plots vs non treated (No HT6 tested) in resistan ce challenged environments, Brazil, 2 trials with each 3 replicates, 2025/26 growing season, post -emergence soybean treatments were standardized across all trials
Page 93
32 /// Bayer Crop Science 2026 Cropping system design in action | We design multi-year systems that deliver high profit for growers – no-one else can do this! 32 /// Bayer Crop Science 2026 // Field-specific hybrid/density insights // Crop growth & harvest intelligence // Crop planning and field evaluation // Certification/verification policies // Field-specific CP recommendations // Compliance management // Delaro® Complete formulation for late- season fungicide application // LCM measures to extend labels of 6 products3 for use in intermediate crops // Stryax® herbicide formulation // Fluopyram seed treatment (SDS) // Bred Short Statue Corn hybrids // Traits for further enhancement // Excellent yield potentials from genetics // Genome Editing enabled 'standability'2 Digital Solutions Crop Protection Seeds and Traits // Leverage Genome Editing to modify maturity and oil content Year 1 Year 2 LCM = Lifecycle management, SDS = Sudden Death Sysndrome (Fluopyram protects seedlings against Fusarium virguliforme, the main causal pathogen) 1. Pending EPA label approval; This product is not currently available for commercial sale or commercial planting. Commercialization is dependent on multiple factors, including successful conclusion of the regulatory process. The information presented herein is provided for educational purposes only, and is not and shall not be construed as an offer to sell. 2. First GE soy market launches in th e early 2030s 3. Total CP bandwidth is supported: HER, FUN and INS 1 Examples
Page 94
33 /// Bayer Crop Science 2026 Clear answers for the future of our R&D /// Bayer Crop Science 202633 Innovation in agriculture matters more than ever! Relevance Competition We are leading in every tech platform and the only company able to design unique systems for step-change value creation Race Our pipeline is stronger than ever, our future innovations deliver unprecedented value for growers and strong competitive advantage for us Return Seeds with strong yield advantage in all our crops Best-in-class traits for weed and insect protection New CP MoA with superior performance – safe by design Crop systems designed to maximize grower profits
Page 95
34 /// Bayer Crop Science 2026 Thank You 2nd September 2026 Huxley, IA
Page 96
35 /// Bayer Crop Science 2026 Cautionary Statements Regarding Forward-Looking Information This presentation may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at h t t p : / / w w w. b a y e r. c o m/
Page 97
36 /// Bayer Crop Science 2026 Legal claims and commercialization statements ALWAYS READ AND FOLLOW PESTICIDE LABEL DIRECTIONS. This material may contain “forward-looking statements” based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at http://www.bayer.com/. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments. These products are not currently available for commercial sale or commercial planting. Commercialization is dependent on multiple factors, including successful conclusion of the regulatory process. The information presented herein is provided for educational purposes only, and is not and shall not be construed as an offer to sell. Bayer is a member of Excellence Through Stewardship® (ETS). Bayer's biotechnology-derived products are commercialized in accordance with ETS Product Launch Stewardship Guidance, and in compliance with Bayer’s Policy for Commercialization of Biotechnology-Derived Plant Products in Commodity Crops. Where applicable, commercialized products have been approved for import into key export markets with functioning regulatory systems. Any crop or material produced from commercialized products can only be exported to, or used, processed or sold in countries where all applicable regulatory approvals have been granted. It is a violation of national and international law to move material containing biotech traits across boundaries into nations where import is not permitted. Growers should talk to their grain handler or product purchaser to confirm their buying position for commercialized products. Excellence Through Stewardship® is a registered trademark of Excellence Through Stewardship. Certain practices may be subject to state acre enrollment limits. The regenerative agriculture program described in this material is subject to the current version of the Bayer Carbon-Smart Practices Master Agreement and attached program terms. The information is to aid in the understanding of the program and does not change or modify the Bayer Carbon-Smart Practices Master Agreement and attached program terms in any way. The Preceon Smart Corn System, including short stature corn products developed through traditional breeding, is commercially available for planting in the 2026 growing season through a Preceon Certified Advisor. Preceon Smart Corn System hybrids, developed through biotechnology, are not currently available for commercial sale or commercial planting. Commercialization is dependent on multiple factors, including successful conclusion of the regulatory process. The information presented herein is provided for educational purposes only, and is not and shall not be construed as an offer to sell. It is a violation of federal and state law to use any pesticide product other than in accordance with its labeling. NOT ALL formulations of glyphosate, dicamba, glufosinate, mesotrione, or 2,4-D are being pursued for regulatory approval for in-crop use with Vyconic Soybeans. ONLY USE FORMULATIONS THAT ARE SPECIFICALLY LABELED FOR SUCH USES AND APPROVED FOR SUCH USE IN THE STATE OF APPLICATION. Contact the U.S. EPA and your state pesticide regulatory agency with any questions about the approval status of herbicide products for in-crop use. See the IRM/Grower Guide for additional information. Always read and follow IRM requirements. B.t. products may not yet be registered in all states. Contact the U.S. EPA and your state pesticide regulatory agency with any questions about the approval status of herbicide products for in-crop use. Performance may vary, from location to location and from year to year, as local growing, soil and environmental conditions may vary. Growers should evaluate data from multiple locations and years whenever possible and should consider the impacts of these conditions on their growing environment. The recommendations in this material are based upon trial observations and feedback received from a limited number of growers and growing environments. These recommendations should be considered as one reference point and should not be substituted for the professional opinion of agronomists, entomologists or other relevant experts evaluating specific conditions. IMPORTANT IRM INFORMATION: Certain products are sold as RIB Complete® corn blend products, and do not require the planting of a structured refuge except in the Cotton-Growing Area where corn earworm is a significant pest. Products sold without refuge in the bag (non-RIB Complete) require the planting of a structured refuge. See the IRM/Grower Guide for additional information. Always read and follow IRM requirements. Roundup Ready® 2 Technology contains genes that confer tolerance to glyphosate. Plants that are not tolerant to glyphosate may be damaged or killed if exposed to those herbicides. Vyconic Soybeans contain genes that confer tolerance to glyphosate, glufosinate, dicamba, mesotrione, or 2,4-D. Plants that are not tolerant to glyphosate, dicamba, glufosinate, mesotrione, or 2,4-D may be damaged or killed if exposed to those herbicides. Contact your seed brand dealer or refer to the Bayer Technology Use Guide for recommended weed control programs. Insect control technology provided by Vip3A is utilized under license from Syngenta Crop Protection AG. TriVolt is a restricted use pesticide. The distribution, sale, or use of an unregistered pesticide is a violation of federal and/or state law and is strictly prohibited. Check with your state department(s) of agriculture, local dealer or representative for the product registration status in your state. Not all products are registered for use in all states and may be subject to use restrictions. Services and products offered by Bayer CropScience LLC, through the FieldView platform, are subject to the customer agreeing to our Terms of Service. Our services provide estimates or recommendations based on models. These do not guarantee results. Consult with your agronomist, commodity broker, or other industry professional before making financial, farming, or risk management decisions. More information at https://www.climate.com/legal/disclaimer. FieldView is a trademark of Bayer Group. Agrisure Viptera® is a registered trademark of a Syngenta group company. Respect the Refuge and Corn Design® is a registered trademark of National Corn Growers Association. Acceleron®, Bayer, Bayer Cross, Convintro , DEKALB®, Delaro®, Ground Breakers®, Preceon , Roundup Ready 2 Technology and Design®, Roundup Ready®, ThryvOn® Technology, Trecepta®, TriVolt , VT Double PRO® and Vyconic are trademarks of Bayer Group. All other trademarks are the property of their respective owners. For additional product information call toll-free 1-866-99-BAYER (1-866-992-2937) or visit our website at www.BayerCropScience.us. Bayer CropScience LLC, 800 North Lindbergh Boulevard, St. Louis, MO 63167. ©2026 Bayer Group. All rights reserved.